Cyclosporine is the gold standard for treating atopic dermatitis in adults requiring systemic treatment, but there are numerous other molecules being explored. Dupilumab, tralokinumab, Janus kinase inhibitors, and other molecules have shown promise for treating atopic dermatitis in both adults and children. Lebrikizumab, nemolizumab, rocatinlimab, amlitelimab, temtokibart, and tapinarof are among the other drugs being researched. These medications target various mechanisms involved in atopic dermatitis and are showing promising results in clinical trials. The innovation in the field of atopic dermatitis treatment is ongoing, and several new drugs are currently under investigation.
Source link
New Molecules Reflect Advances in Atopic Dermatitis
